Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. United Kingdom
  4. London Stock Exchange
  5. AstraZeneca PLC
  6. News
  7. Summary
    AZN   GB0009895292

ASTRAZENECA PLC

(AZN)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

AstraZeneca : Gets US FDA's Orphan Drug Designation for Eosinophilic Esophagitis Drug

10/08/2021 | 08:28am EST


ę MT Newswires 2021
All news about ASTRAZENECA PLC
03:26pAstraZeneca Explores Listing of Newly-Created Vaccines Unit
MT
03:08pAstraZeneca Reportedly Weighs Listing of Newly-Created Vaccines Unit
MT
01:14pEuropean Stocks Close Lower After Disappointing US Jobs Data
MT
05:40aSobi Down 23% After AstraZeneca Said to Block Advent, GIC's Takeover Bid
MT
02:32aHutchmed's Two Cancer Therapies Included in China's Drug Reimbursement List
MT
02:12aASTRAZENECA : reinforces leadership in breast cancer at SABCS 2021 with new data underscor..
PU
12/02Pfizer-BioNTech, Moderna's COVID-19 Jabs Offer Best Immunity Boost, UK Study Says
MT
12/02What COVID-19 vaccine and drug makers have to say about Omicron
RE
12/01Scientists Discover Cause Behind Blood Clot Formation After AstraZeneca Vaccine
MT
12/01Abbisko Unit Doses First Patient in China Phase II Trial of Urothelial Cancer Therapy
MT
More news
Analyst Recommendations on ASTRAZENECA PLC
More recommendations
Financials (USD)
Sales 2021 35 919 M - -
Net income 2021 3 423 M - -
Net Debt 2021 25 253 M - -
P/E ratio 2021 36,9x
Yield 2021 2,60%
Capitalization 168 B 168 B -
EV / Sales 2021 5,38x
EV / Sales 2022 4,40x
Nbr of Employees 76 100
Free-Float 96,4%
Chart ASTRAZENECA PLC
Duration : Period :
AstraZeneca PLC Technical Analysis Chart | AZN | GB0009895292 | MarketScreener
Technical analysis trends ASTRAZENECA PLC
Short TermMid-TermLong Term
TrendsBearishNeutralBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 25
Last Close Price 108,38 $
Average target price 137,48 $
Spread / Average Target 26,9%
EPS Revisions
Managers and Directors
Pascal Soriot Chief Executive Officer & Executive Director
Aradhana Sarin Chief Financial Officer & Executive Director
Leif Valdemar Johansson Non-Executive Chairman
Menelas NICOLAS Pangalos EVP-Biopharmaceuticals Research & Development
Pam P. Cheng Executive VP-Operations & Information Technology
Sector and Competitors
1st jan.Capi. (M$)
ASTRAZENECA PLC11.84%169 712
JOHNSON & JOHNSON-0.18%413 555
ROCHE HOLDING AG17.62%341 509
PFIZER, INC.44.09%297 706
NOVO NORDISK A/S64.51%243 534
ELI LILLY AND COMPANY47.55%224 726